English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51933246    線上人數 :  1002
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"jen chang ko"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 156-180 / 290 (共12頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-03-11T08:34:15Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:34:15Z Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:34:15Z Effect of β-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Lee C.-H.; JEN-CHANG KO; LIH-YU CHANG; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T08:34:14Z Capsaicin Acts Through Reducing P38 MAPK-Dependent Thymidylate Synthase Expression to Enhance 5-Fluorouracil-Induced Cytotoxicity in Human Lung Cancer Cells Tung C.-L.; Chen J.-C.; JEN-CHANG KO; Liu L.-L.; Chien C.-C.; Huang I.-H.; Tsao Y.-C.; Cheng H.-H.; Chen T.-Y.; Yen T.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:45Z Lobar bronchioloalveolar carcinoma: an ultrasound study. JEN-CHANG KO; Yang P.C.; Luh K.T.; Kuo S.H.; Chang D.B.; Yu C.J.
臺大學術典藏 2021-03-11T08:29:45Z Superior vena cava syndrome: Rapid histologic diagnosis by ultrasound- guided transthoracic needle aspiration biopsy JEN-CHANG KO; Yang P.-C.; Yuan A.; Chang D.-B.; Yu C.-J.; Wu H.-D.; Lee L.-N.; Kuo S.-H.; Luh K.-T.
臺大學術典藏 2021-03-11T08:29:44Z Panhypopituitarism caused by solitary parasellar metastasis from lung cancer JEN-CHANG KO; Yang P.-C.; Huang T.-S.; Yeh K.-H.; Kuo S.-H.; Luh K.T.
臺大學術典藏 2021-03-11T08:29:44Z Ultrasonographic evaluation of peridiaphragmatic lesions: A prospective study JEN-CHANG KO; Yang P.-C.; Chang D.-B.; Yu C.-J.; Lee L.-N.; Kuo S.-H.; Luh K.-T.
臺大學術典藏 2021-03-11T08:29:44Z Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion Lee L.-N.; Luh K.-T.; Yang P.-C.; Chang D.-B.; Yu C.-J.; JEN-CHANG KO; Liaw Y.-S.; Wu R.-G.
臺大學術典藏 2021-03-11T08:29:43Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:43Z Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:43Z Disseminated coccidioidomycosis [8] Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H.
臺大學術典藏 2021-03-11T08:29:43Z Disseminated coccidioidomycosis [8] Wang C.-Y.;Jerng J.-S.;Jen-Chang Ko;Lin M.-F.;Hsiao C.-H.;Lee L.-N.;Hsueh P.-R.;Kuo S.-H.; Wang C.-Y.; Jerng J.-S.; JEN-CHANG KO; Lin M.-F.; Hsiao C.-H.; Lee L.-N.; Hsueh P.-R.; Kuo S.-H.
臺大學術典藏 2021-03-11T08:29:43Z Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L.
臺大學術典藏 2021-03-11T08:29:43Z Dual and opposing roles of ERK in regulating G1 and S-G 2/M delays in A549 cells caused by hyperoxia Jen-Chang Ko;Wang Y.-T.;Yang J.-L.; JEN-CHANG KO; Wang Y.-T.; Yang J.-L.
臺大學術典藏 2021-03-11T08:29:43Z The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:43Z The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:42Z The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:42Z Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:42Z Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:42Z Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:41Z Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:41Z Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:41Z Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W.
臺大學術典藏 2021-03-11T08:29:41Z Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.

顯示項目 156-180 / 290 (共12頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目